Refine by
Genomics Product Articles & Analysis
21 news found
The biological reagents previously launched by Alfa Chemistry encompass transilluminator, proteomic products (i.e., Protein Marker/Ladder, Western Substrate, Protein Staining Reagent, OneStep Blocker, UltraScence TMB ELISA Substrate), genomic products (i.e., DNA Marker/Ladder, Staining Reagent, Agarose, PCR Reagent, RNA Reagent, Real-Time PCR ...
CD Genomics, a global leader in genomics solutions, has recently unveiled its highly anticipated DAP-Seq service. ...
CD Genomics, a renowned provider of genomics services, is proud to unveil its cutting-edge Whole Exome Sequencing (WES) service. ...
The Product Manager at CD Genomics is pleased to announce the launch of the LC-MS/MS Data Analysis service, enabling high-performance, regulated bioanalysis of small molecules, peptides, and proteins. ...
The e[datascientist] platform enables enterprise customers to trace digital journeys in data, driving transformative innovations, exploiting leading-edge scientific discovery in silico and supporting differentiated product claims. Eagle Genomics’ purpose is to accelerate the Bioeconomy through the digital reinvention of life sciences R&D, and the ...
This year, it attracts a great number of researchers who are interested in accelerating oligonucleotide, peptide, mRNA, and genome editing products from early discovery to late-stage development and commercialization. ...
“Foundation Medicine’s deep regulatory and genomics expertise makes us an essential partner for companies like Lilly who share our commitment to transforming cancer care,” said Sanket Agrawal, MPH, MBA, chief biopharma business officer at Foundation Medicine. ...
C2i Genomics, a cancer intelligence company, today announced expansion into Europe through a strategic partnership with OncoDNA, a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases. ...
The test is FDA-approved to report short variants in over 300 genes and is a companion diagnostic to identify patients who may benefit from treatment with specific therapies (listed in Table 1 of the Intended Use) in accordance with the approved therapeutic product labeling. Additional genomic findings may be reported and are not prescriptive or conclusive for ...
Deep Genomics, the leading AI therapeutics company, welcomes Tal Zaks, M.D., Ph.D., to its Strategic Advisory Board, effective today. ...
These days, the product manager of CD Genomics announced the m5C profiling services to help researchers deeply understand the role of RNA modification in life and disease, and promote accurate diagnosis and treatment of diseases. 5mC is one of the most common and abundant methylation modifications in the transcriptome, and it is very common in mRNA and some ...
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Deep Genomics today announced that the companies have entered into a preclinical collaboration that will use Deep Genomics’ artificial intelligence drug discovery platform (The AI Workbench) to identify oligonucleotide drug candidates in four rare disease indications with high unmet need. ...
Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and custom assay development on dedicated clinical instruments. ...
(NYSE: A) today announced new additions to its market-leading SureSelect target-enrichment product family, which has already enabled researchers to identify more than 50 Mendelian disease-causing genes. ...
"Expanding functionality of this innovative system is as easy as replacing a printer's toner cartridge," said Alessandro Borsatti, senior director of marketing for Agilent's Diagnostics and Genomics group. "The instrument is set up to accommodate detection and visualization of up to six fluorophores, and our unique modular design also enables easy expansion if additional fluors ...
Agilent will feature a variety of its pathology and genomics solutions, including several new products. Throughout the symposium, delegates will be able to see live demonstrations of the company's newest pathology solution, Dako Omnis, at Booth 6. ...
In addition to its new integrated headquarters, plant biotechnology and genomics center and expanded greenhouse facilities in San Diego, SGB's commercial and operational advancements include: Establishment of a seed production facility in Guatemala where the company is scaling its operational capacity to produce large volumes of elite hybrid Jatropha seed. ...
"It is highly desired by the cancer genomics community to have a single platform that embraces the advantages of both CGH and SNP arrays," said Marilyn M. ...
SureSelect has been shown to greatly increase the speed and cost-efficiency of next-generation sequencing by enabling researchers to focus experiments on genomic regions of interest rather than sequencing the entire genome. ...
"We're honored to play a key role in this major effort," said Robert Schueren, Agilent vice president and general manager, Genomics. "We're pleased to provide these multinational teams with technical guidance, as well as genomics products, to support accurate, consistent results." ...